Phase I trial of BGC 200134 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2010
At a glance
- Drugs BGC 200134 (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors BTG
- 22 Jan 2010 Status changed from recruiting to completed as reported in a BTG International media release.
- 22 Jul 2008 Phase II trial planned to start in the first half of 2009 according to BTG media relase.
- 02 Apr 2008 Results are expected in the second half of 2008, according to a BTG media release.